We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.75B
1-Year Est. Return 46.53%
This Fund
S&P 500
This Quarter Est. Return
+9.26%
1 Year Est. Return
+46.53%
3 Year Est. Return
+120.27%
5 Year Est. Return
+150.66%
10 Year Est. Return
+646.21%
AUM
$2.21B
AUM Growth
+$110M
Cap. Flow
-$79.3M
Cap. Flow %
-3.59%
Top 10 Hldgs %
22.7%
Holding
3,121
New
66
Increased
341
Reduced
717
Closed
30

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$3.73M
2
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$3.01M
3
COP icon
ConocoPhillips
COP
+$2.6M
4
NOW icon
ServiceNow
NOW
+$1.95M
5
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$1.95M

Top Sells

Rank Stock Value
1
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$6.14M
2
MSFT icon
Microsoft
MSFT
+$4.3M
3
VOO icon
Vanguard S&P 500 ETF
VOO
+$3.96M
4
TER icon
Teradyne
TER
+$3.85M
5
ETSY icon
Etsy
ETSY
+$3.81M

Sector Composition

Rank Sector Weight
1 Technology 17.97%
2 Consumer Discretionary 10.47%
3 Healthcare 9.98%
4 Financials 9.67%
5 Industrials 9.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRVB
1851
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$48K ﹤0.01%
3,744
– –
CNST
1852
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$48K ﹤0.01%
2,388
– –
APOG icon
1853
Apogee Enterprises
APOG
$885M
$47K ﹤0.01%
2,204
– –
BDTX icon
1854
Black Diamond Therapeutics
BDTX
$117M
$47K ﹤0.01%
1,541
+491
+47% +$14.9K
CARS icon
1855
Cars.com
CARS
$652M
$47K ﹤0.01%
5,846
– –
CRMT icon
1856
America's Car Mart
CRMT
$25.1M
$47K ﹤0.01%
548
– –
GLNG icon
1857
Golar LNG
GLNG
$5.33B
$47K ﹤0.01%
7,757
-723
-9% -$6.47K
GPRO icon
1858
GoPro
GPRO
$111M
$47K ﹤0.01%
10,449
– –
GRC icon
1859
Gorman-Rupp
GRC
$2.11B
$47K ﹤0.01%
1,579
– –
IMKTA icon
1860
Ingles Markets
IMKTA
$1.66B
$47K ﹤0.01%
1,243
– –
INN
1861
Summit Hotel Properties
INN
$656M
$47K ﹤0.01%
8,982
– –
NTR icon
1862
Nutrien
NTR
$32.5B
$47K ﹤0.01%
1,215
– –
PDFS icon
1863
PDF Solutions
PDFS
$2.13B
$47K ﹤0.01%
2,532
– –
PRPL icon
1864
Purple Innovation
PRPL
$27.9M
$47K ﹤0.01%
76
+25
+49% +$13.3K
RLMD icon
1865
Relmada Therapeutics
RLMD
$511M
$47K ﹤0.01%
1,242
– –
TCRT icon
1866
Alaunos Therapeutics
TCRT
$4.79M
$47K ﹤0.01%
126
– –
ZUMZ icon
1867
Zumiez
ZUMZ
$315M
$47K ﹤0.01%
1,698
– –
RAD
1868
DELISTED
Rite Aid Corporation
RAD
$47K ﹤0.01%
4,943
– –
KRA
1869
DELISTED
Kraton Corporation
KRA
$47K ﹤0.01%
2,659
– –
MDP
1870
DELISTED
Meredith Corporation
MDP
$47K ﹤0.01%
3,558
– –
EIDX
1871
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$47K ﹤0.01%
939
– –
AHCO icon
1872
AdaptHealth
AHCO
$787M
$46K ﹤0.01%
2,130
+1,437
+207% +$30.2K
CQP icon
1873
Cheniere Energy
CQP
$33.2B
$46K ﹤0.01%
1,385
– –
FTI icon
1874
TechnipFMC
FTI
$30.9B
$46K ﹤0.01%
9,831
– –
GOGO icon
1875
Gogo Inc
GOGO
$383M
$46K ﹤0.01%
5,004
– –
73 74
75
76 77

Similar funds

DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
GCC
Guardian Capital (Canada) Toronto, Ontario, Canada $3.78B AUM 33.04% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return
CI
Cavalier Investments Alpharetta, Georgia $3.7B AUM 51.42% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
EPIM
Evelyn Partners Investment Management London $3.68B AUM 21.15% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

Ameritas Investment Partners's Q3 2020 Portfolio in Review

As of Q3 2020, Ameritas Investment Partners held 3,121 positions worth $2.21B, up 5.2% from $2.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Ameritas Investment Partners withdrew a net $79.3M in Q3 2020, closing 30 positions and reducing 717 holdings. Its most notable exit was Caesars Entertainment Corporation, an estimated $1.97M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Ameritas Investment Partners opened a new position in Jazz Pharmaceuticals worth $2.24M.

  • Ameritas Investment Partners's largest Q3 2020 buy was Jazz Pharmaceuticals: 15,701 shares worth $2.24M.
  • Ameritas Investment Partners added most to Invesco QQQ Trust in Q3 2020, an estimated $3.73M increase.
  • Ameritas Investment Partners's biggest Q3 2020 reduction was State Street SPDR S&P MIDCAP 400 ETF Trust, cutting an estimated $6.14M.
  • Ameritas Investment Partners fully exited Caesars Entertainment Corporation in Q3 2020, selling an estimated $1.97M.
  • Ameritas Investment Partners's ten largest holdings make up 23% of its $2.21B portfolio in Q3 2020.
  • Ameritas Investment Partners opened 66 new positions and closed 30 in Q3 2020.
  • Ameritas Investment Partners's portfolio value rose 5.2% quarter-over-quarter to $2.21B.

Based on Ameritas Investment Partners's 13F filing for Q3 2020, filed 13 Nov 2020.